Generic Rx drugs saved US health system $1 trillion over past decade; study

3 August 2012

Due to the ever growing use of generic prescription medicines, the American health care system saved more than $1 trillion over the last decade, according to a new study released by the Generic Pharmaceutical Association (GPhA).

Savings to consumers and the US health care system from the use of lower cost generic prescription drugs has risen to a current rate of $1 billion every other day - totaling $193 billion in 2011 alone, according to the study, which was conducted for the GPhA by the IMS Institute for Healthcare Informatics, the research division of health care industry information supplier IMS Health.

Govt figs show health spending hit $2.2 billion in 2010

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics